EPITALON
Epitalon (Epithalon) is a synthetic tetrapeptide that activates telomerase, potentially lengthening telomeres and extending cellular lifespan
What is EPITALON?
Epitalon (Epithalon) is a synthetic tetrapeptide that activates telomerase, potentially lengthening telomeres and extending cellular lifespan. Developed by Vladimir Khavinson, it's used primarily for anti-aging and longevity purposes.
Across SelfAssay's corpus, EPITALON appears in 258 first-hand reports from 236 contributors, with overall community sentiment that reads as positive. Most of that discussion centers on Sleep Quality & Insomnia and General Health & Vitality.
On SelfAssay, EPITALON scores A (strong) for effectiveness and A (strong) for safety. These are two independent signals: how reliably people report the benefit they were after, and how often they report adverse effects.
What people use EPITALON for
What users report
From 258 first-hand reports across the community corpus.
What the community says about EPITALON
Users widely praise Epitalon as a powerful tool for resetting circadian rhythms and improving sleep quality, though experiences vary significantly regarding the ideal timing and dosage. Many describe feeling more rested, experiencing deeper sleep, and enjoying faster sleep onset within just a few weeks of starting, with some reporting that it even doubled their REM or deep sleep stages. While common doses range from 100 mcg to 2 mg, some users find it stimulating when taken at night and prefer morning administration, whereas others report that it helps them fall asleep more easily. A few users note cognitive benefits like improved memory retention and mental clarity, but there are notable outliers who report negative side effects, including restless legs, increased anxiety, or persistent early-morning waking that lasted well after their cycle ended.
Reports are largely positive, with many users praising epitalon for its potential anti-aging benefits, telomere lengthening, and improved sleep quality. While some early research and older protocols suggested high doses of 5-10 mg, many users now favor lower, more precise doses ranging from 200 mcg to 1 mg, noting that the higher recommendations likely stemmed from confusion between the crude extract "Epithalamin" and the concentrated synthetic peptide. Most people cycle the compound for 10 to 20 days, often repeating the process every few months or annually, and some report specific benefits like vivid dreaming, mental clarity, and even libido regulation. However, a few users report negative mood side effects or express skepticism regarding the lack of rigorous, large-scale human trials, and some caution that taking it too close to bedtime can interfere with falling asleep.
Users widely praise Epitalon for its potential anti-aging benefits and its ability to regulate circadian rhythms, though experiences vary significantly regarding its immediate impact. Many describe it as a "game changer" for sleep, noting that it promotes deep, restorative rest and helps realign sleep cycles, often within just a few weeks of use. While some users report noticeable boosts in energy and mental clarity, others find the effects more subtle, with a few individuals noting they felt no difference at all. Typical protocols mentioned in the community range from 1mg to 10mg daily, often cycled for 10 to 20 days, with some users opting for these cycles a few times a year. While most report it as a well-tolerated addition to their stacks, a few outliers mention feeling overly tired or sluggish when first starting, suggesting that timing the dose, whether in the morning or before bed, is a matter of personal experimentation.
Themes are clustered from first-hand reports and summarized automatically. They describe what people report, not clinical fact.
Research and evidence for EPITALON
The grades and figures for EPITALON draw on 166 studies and 258 first-hand community reports. Every number on this page is computed from that evidence, not generated: SelfAssay grounds each claim in a classified source and refuses when the data isn't there.
Is EPITALON safe?
EPITALON carries a safety grade of A (strong), derived from the rate at which users report adverse effects rather than from a clinical risk model. The side effects people mention most often are sleep-disturbance, insomnia, sleepiness, and anxiety. This is not a complete safety profile, and EPITALON can interact with other compounds and existing conditions. Review any plan with a qualified clinician before use.
Frequently asked questions
What is EPITALON?
Epitalon (Epithalon) is a synthetic tetrapeptide that activates telomerase, potentially lengthening telomeres and extending cellular lifespan. Developed by Vladimir Khavinson, it's used primarily for anti-aging and longevity purposes.
What is EPITALON used for?
In SelfAssay's community corpus, EPITALON is most often used for Sleep Quality & Insomnia and General Health & Vitality. Each use case is graded separately, based on how consistently users report the result they were after.
What effects do people report from EPITALON?
The most frequently reported effects are improved sleep, longevity, telomere lengthening, circadian-rhythm-regulation, and increased energy. Overall community sentiment toward EPITALON reads as positive, drawn from 258 first-hand reports.
What are the side effects of EPITALON?
The side effects users mention most often are sleep-disturbance, insomnia, sleepiness, anxiety, and waking-up-early. These are self-reported and not a complete safety profile; consult a clinician before use.
Is EPITALON safe?
SelfAssay grades EPITALON A (strong) on safety, based on how often users report adverse effects. This is decision support, not medical advice, and it does not account for your individual health context.
How effective is EPITALON?
EPITALON holds an effectiveness grade of A (strong) on SelfAssay, with its strongest grade for Sleep Quality & Insomnia. Grades reflect aggregated user experience and published research, not a guarantee of results.
How much research is there on EPITALON?
SelfAssay's view of EPITALON draws on 166 studies and 258 first-hand community reports, refreshed as new evidence is published.
Grade your own stack, free
See how EPITALON scores alongside everything else you take, across effectiveness, safety, synergy, and interactions, grounded in the same reports and literature.
Grade my stackDecision support, not medical advice. Grades reflect community-reported experience and published literature, not a clinical assessment of your individual case. EPITALON is provided for informational purposes; consult a qualified clinician before use.